Appropriate insulin level in selecting fortified diet-fed, streptozotocin-treated rat model of type 2 diabetes for anti-diabetic studies

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Okoduwa, Stanley Irobekhian Reuben ^a,b   Umar, Ismaila A ^a   James, Dorcas B ^a   Inuwa, Hajiya M ^a  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

^b Nigeria Institute of Leather and Science Technology   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DRINKING WATER; FRUCTOSE; GLIBENCLAMIDE; INSULIN; MARGARINE; METFORMIN; PIOGLITAZONE; TRIACYLGLYCEROL; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC DIET; DISEASE SEVERITY; FOOD PREFERENCE; FORTIFIED FOOD; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; THERAPY EFFECT; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DISEASE MODEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FOOD, FORTIFIED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

EID: 85010957509     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0170971     Document Type: Article

References (50)

1. International Diabetes Federation, (IDF). Atlas, 7th edition, 2015. http://idf.org/diabetesatlas 2015
2. ADA. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Position statement. Diabetes Care. 2014; 37(S1): S81-S90
3. International Diabetes Federation (IDF). Diabetes Atlas. 6th edition, Brussels, Belgium. http://idf.org/ diabetesatlas. 2013
4. Schaalan M, El-Abhar HS, Barakat M, El-Denshary ES. Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone andglimepiride. J Diabetes Complications. 2009; 23(3): 199-208. doi: 10.1016/j.jdiacomp.2008.02.003PMID: 18407527
5. Willett WC. Dietary fat plays a major role in obesity. Obes Rev. 2002; 3(2): 59-68. PMID: 12120421
6. Atawodi SE. Antioxidant potential of African medicinal plants. Afr J Biotechnol. 2005; 4 (2): 128-133.Article number: 207084D9354.
7. Al-awar A, Kupai K, Veszelka M, szucs G, Attieh Z, Murlasits Z, Torok S, Posa A, Varga C. Experimental diabetes mellitus in different animal models. J. Diab. Res. 2016: Article ID: 9051426 12 pages.
8. Zarfeshani A, Mutalib MSA, Khaza'ai H. Evaluating of high fructose diet to induce hyperglycaemia and its inflammatory complications in rats. Pak J Nutr. 2012; 11:21-26.
9. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J Med Res.2007; 125: 451-472. PMID: 17496368
10. Holman RR. Type 2 diabetes mellitus in 2012: Optimal management of type 2 diabetes mellitus remains elusive. Nat Rev Endocrinol. 2013; 9(2): 67-68. doi: 10.1038/nrendo.2012.243 PMID: 23296166
11. Eddouks M, Chattopadhyay D, Zeggwagh NA. Review Article: Animal Models as Tools to Investigate Antidiabetic and Anti-Inflammatory Plants. Evid Based Complement Alternat Med. 2012; Article ID142087, 14 pages
12. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat and multiple low-dose streptozotocin induced type 2 diabetes rat model.Exp Diabetes Res. 2008;
13. Modu S, Adeboye AE, Maisaratu A, Mubi BM. Studies on the administration of Vernonia amygdalina Del. (Bitter leaf) and glucophage on blood glucose level of alloxan-Induced diabetic rats. Int J Med Plant Alternat Med. 2013; 1(1): 013-019
14. Khan HB, Vinayagam KS, Moorthy BT, Palanivelu S, Panchnatham S. Anti-inflamatory and anti-hyperlipidemic effect of Semecarpus anacardium in a high fat diet: STZ-induced type 2 diabetes. Inflammopharmacol. 2013; 21: 37-46.
15. Okon UA, Owo DU, Udokang NE, Udobang JA, Ekpenyong CE. Oral Administration of Aqueous Leaf Extract of Ocimum Gratissimum Ameliorates Polyphagia, Polydipsia and Weight Loss in Streptozotocin-Induced Diabetic Rats.Am J Med Med Sci. 2012; 2(3): 45-49.
16. Akpaso MI, Atangwho IJ, Akpantah A, Fischer VA, Igiri AO, Ebong PE. Effect of Combined Leaf Extracts of Vernonia amygdalina (Bitter Leaf) and Gongronema latifolium (Utazi) on the Pancreatic β-Cells of Streptozotocin- Induced Diabetic Rats. Br J Med Med Res. 2011; 1(1): 24-34
17. Sasidharan SR, Joseph JA, Anandakumar VV, Madhavan CAN, Agarwal A. An experimental approach for selecting appropriate rodent diet for research studies on metabolic disorders.BioMed Res Int. 2013.PMCID: PMC3787574
18. Gajda AM, Pellizzon MA, Ricci MR, Ulman EA. Diet-induced metabolic syndrome in rodent models. Animal Lab News. 2007
19. Skovso S. Modelling type 2 diabetes in rats using high fat diet and streptozotocin. JDiabetes Investig. 2014; 5(4): 349-357.
20. Cantley J, Ashcroft FM. Q&A insulin secretion and type 2 diabetes. Why do beta-cell fail? BMC Biol. 2015; 13:33. doi: 10.1186/s12915-015-0140-6 PMID: 25982967
21. Herold KC, Usman-Brown S, Ghazi T, Lebastchi J, Beam CA, Bellin MD, Ledizet M, Sosenko JM, Krischer JP, Palmer JP. B-cell death and dysfunction during type 1 diabetes development in at-risk individual. JClinInvest. 2015; 125(3): 1163-1173.
22. Nepton S. Beta-cell function and failure. INTECH. Endocrinol Metab. 2013; 115-126.
23. Fasola TR, Okeocha PC, Odetola A. Screening for hypoglycaemic potentials of the extracts of Vernonia amygdalina. Ethnobot Leaflets. 2010; 14: 759-65
24. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005; 52: 313-320. doi: 10.1016/j.phrs.2005.05.004 PMID: 15979893
25. Wilson RD, Islam S. Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. Pharmacol Rep. 2012; 64: 129-139. PMID: 22580529
26. Leiter EH. Selecting the 'right' mouse model for metabolic syndrome and type 2 diabetes research. Methods MolBiol. 2009; 560: 1-17.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7): 412-419. PMID: 3899825
28. Hu SH, Jiang T, Yang SS, Yang Y. Pioglotazone ameliorates intracerebral insulin resistance and tauprotein hyperphosphorylation in rats with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013; 121: 220-224. doi: 10.1055/s-0032-1333277 PMID: 23512416
29. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metab. 2000; 49: 1390-1394.
30. King AJF. The use of animal models in diabetes research. Br J Pharmacol. 2012; 166:877-894 doi: 10. 1111/j.1476-5381.2012.01911.x PMID: 22352879
31. Yoon SS, Rhee YH, Lee HJ, Lee EO, Lee MH, Ahn KS, et al. Uncoupled protein 3 and p38 signal pathways are involved in anti-obesity activity of Solanum tuberosum I. cv. Bora valley. JEthnopharmacol.2008; 118(3): 396-404.
32. Franconi F, Seghieri G, Ganus. Straface E, Campesi I, Malorni W. Are the available experimental models of type 2 diabetes appropriate for gender perspective? Pharmacol Res. 2008; 57: 6-18. doi: 10. 1016/j.phrs.2007.11.007 PMID: 18221886
33. de Moura RF, Ribeiro C, de Oliveira JA, Stevanato E, de Mello MAR. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. Br J Nutr. 2008; 101: 1178. doi: 10. 1017/S0007114508066774 PMID: 19007450
34. Dupas J, Goanvec C, Feray A, Guernec A, Alain C, Guerrero F, et al. Progressive Induction of Type 2Diabetes: Effects of a Reality-Like Fructose Enriched Diet in Young Wistar Rats. PLoS ONE. 2016; 11 (1): e0146821. PMCID: PMC4723014 doi: 10.1371/journal.pone.0146821 PMID: 26799836
35. Bantle JP. Is fructose the optimal low glycaemia index sweetner. Nestle Nutr Workshop Ser Clin Perform Programme. 2006; 11: 83-95 doi: 10.1159/000094427 PMID: 16820733
36. Basciano H, Federico L, Adeli K. Fructose, insulin resistance and metabolic dyslipedimia. NutrMetab.2005; 2:5.
37. Mamikutty N, Thent ZC, Sapri SR, Sahruddin NN, Mohd-Yusof MR, Haji-Suhaimi F. The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats. BioMed ResInt. 2014, Article ID 263897, 8 pages.
38. Schlmerich BR, Bollheimer LC. High fat diets: modeling the metabolic disorders of human obesity in rodents. Obes. 2007; 15(4): 798-808.
39. Stark AH, Timar B, Madar Z. Adaptation of sprague-dawley rats to long-term feeding of high fat or high fructose diets. Eur JNutr.2000; 39: 229-234.
40. Han D, Hansen PA, Host HH, Holloszy JO. Insulin resistance of muscle glucose transport in rats fed a high-fat diet. Diabetes. 1997; 46: 1761-1767 PMID: 9356023
41. Kuate D, Pascale A, Kengne N, Biapa CPN, Azantsa BGK, Muda WABW. Tetrapleura tetraptera spice attenuates high-carbohydrate, high-fat diet-induced obese and type 2 diabetic rats with metabolic syndrome features. Lipids Health Dis. 2015; 14(50): 13pages. PMICD: PMC4448292
42. Wang G. (2014). Raison d'etre of insulin resistance: the adjustable threshold hypothesis, J R SocInterface. 2014; 11(101): 20140892.
43. Klinke DJ II. Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus. PlosONE. 2008; 3(1):e1374.
44. Gale EA. Can we change the course of beta-cell destruction in type 1 diabetes? N EnglJ Med. 2002; 340: 1740-1742.
45. Kargar C, Ktorza A. Anatomical versus functional beta-cell mass in experimental diabetes.Diabetes Obes Metab.2008; 10(Suppl4): 43-53.
46. Suman RK, Mohanty IR, Borde MK, Maheshwari U, Deshmukh YA. Development of an Experimental Model of Diabetes Co-Existing with Metabolic Syndrome in Rats. Adv Pharmacol Sci. 2016, Article ID 9463476, 11 pages PMICD: PMC4736803
47. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, et al. Experimental NIDDM. Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998; 47: 224-229. PMID: 9519717
48. Dhansh KB, Suguna R, Satyanarayana ML. Serum insulin levels and lipid profiles of streptozotocin induced diabetic wistar rats. J Indian Vet Assoc. 2012; 10(2): 22-26
49. Hoogwerf B, Goetz F. Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet and corticosteroids. J Endocrinol Metab. 1983; 56(1): 60-67.
50. Matveyenko AV, Butler PC. Relationship between B-cell mass and diabetes onset. Diabetes Obes Metab.2008; 10(4): 23-31.